Gastric Post-Transplant Lymphoproliferative Disorder after Allogenic Stem Cell Transplantation
نویسندگان
چکیده
Gastroenterology Medicine & Research Gastric Post-Transplant Lymphoproliferative Disorder after Allogenic Stem Cell Transplantation Legarda M1, Garcia-Alberdi E2, Lopez-Almaraz R3, Berastegui M4, Irastorza I1,5, Vitoria JC1,5 and Astigarraga I3,5* 1Pediatric Unit, Department of Pediatrics, Cruces University Hospital, Biocruces Bizkaia Health Institute, Spain 2Department Histopathology, 3Pediatric Haematology Oncology Pediatrics. Hospital. Bizkaia. 4Department Pediatric Radiology, 5Department Basque Country University, *Corresponding author: Itziar Astigarraga, Head the Barakaldo, Bizkaia, Submission:December 21, 2021;Published: January 10, 2022 DOI: 10.31031/GMR.2022.06.000642 ISSN 2637-7632Volume6 Issue4
منابع مشابه
Post Transplant Lymphoproliferative Disorders After Liver Transplantation
Post-transplant lymphoproliferative disorder (PTLD) is a clearly recognized and potentially life threatening complication after solid organ or bone marrow transplantation. It comprises a spectrum of diseases ranging from infectious mononucleosis and lymphoid hyperplasia to highly aggressive lymphoma. The disease has increased clinical importance in view of the constantly rising number of organ ...
متن کاملPost-transplant lymphoproliferative disorder.
BACKGROUND Posttransplant lymphoproliferative disorder (PTLD) is increasingly recognized as a serious complication of solid organ transplantation in both children and adults. Factors associated with increased risk of PTLD include mismatch of recipient and donor EBV serologic status (seronegative recipient with seropositive donor), and intensive drug-induced immunosuppression. METHODS AND RESU...
متن کاملRituximab is highly effective for pure red cell aplasia and post-transplant lymphoproliferative disorder after unrelated hematopoietic stem cell transplantation
Pure red cell aplasia (PRCA) and post-transplant lymphoproliferative disorder (PTLD) constitute rare complications after allogeneic hematopoietic stem cell transplantation (AlloHSCT). The incidence of EBV-PTLD is above 1%, but it may increase in patients with well-known risk factors such as EBV seronegativity at the time of transplantation, T-cell depletion of donor grafts, HLA mismatch and use...
متن کاملEndobronchial Epstein-Barr Virus Associated Post-transplant Lymphoproliferative Disorder in Hematopoietic Stem Cell Transplantation
The Epstein-Barr virus (EBV) associated Post-Transplant Lymphoproliferative Disorders (PTLD) are increasingly recognized as a fatal complication of hematological stem cell transplantation (HSCT). Thoracic involvement, that may be isolated or part of a disseminated disease, usually encompasses pulmonary nodules or masses and mediastinal lymph node enlargement. The current case study presents 2 p...
متن کاملPediatric T-cell post-transplant lymphoproliferative disorder after solid organ transplantation.
Post-transplant lymphoproliferative disorder (PTLD) is the most common treatment related malignancy that occurs after solid organ transplantation (SOT). PTLD has extended from its initial description as an Epstein-Barr virus (EBV)-driven B-cell proliferation to include EBV-negative and non B-lineage cases. T-cell PTLD (T-PTLD) is rare in both adults and children. We report two cases of pediatri...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Gastroenterology medicine & research
سال: 2022
ISSN: ['2637-7632']
DOI: https://doi.org/10.31031/gmr.2022.06.000642